These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9661650)

  • 41. Paraoxonase 1 mutations in a Turkish population.
    Aynacioglu AS; Cascorbi I; Mrozikiewicz PM; Nacak M; Tapanyigit EE; Roots I
    Toxicol Appl Pharmacol; 1999 Jun; 157(3):174-7. PubMed ID: 10373401
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic variation of a collagen IV alpha 1-chain gene polymorphism in Danish insulin-dependent diabetes mellitus (IDDM) patients: lack of association to nephropathy and proliferative retinopathy.
    Chen JW; Hansen PM; Tarnow L; Hellgren A; Deckert T; Pociot F
    Diabet Med; 1997 Feb; 14(2):143-7. PubMed ID: 9047092
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
    Sanguinetti SM; Brites FD; Fasulo V; Verona J; Elbert A; Wikinski RL; Schreier LE
    Diabetes Nutr Metab; 2001 Feb; 14(1):27-36. PubMed ID: 11345163
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Paraoxonase gene polymorphisms and plasma oxidized low-density lipoprotein level as possible risk factors for exudative age-related macular degeneration.
    Ikeda T; Obayashi H; Hasegawa G; Nakamura N; Yoshikawa T; Imamura Y; Koizumi K; Kinoshita S
    Am J Ophthalmol; 2001 Aug; 132(2):191-5. PubMed ID: 11476678
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tobacco smoking modifies association between Gln-Arg192 polymorphism of human paraoxonase gene and risk of myocardial infarction.
    Sen-Banerjee S; Siles X; Campos H
    Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2120-6. PubMed ID: 10978258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic polymorphism in paraoxonase is a risk factor for childhood focal segmental glomerulosclerosis.
    Frishberg Y; Toledano H; Becker-Cohen R; Feigin E; Halle D
    Am J Kidney Dis; 2000 Dec; 36(6):1253-61. PubMed ID: 11096050
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Common paraoxonase gene variants, mortality risk and fatal cardiovascular events in elderly subjects.
    Heijmans BT; Westendorp RG; Lagaay AM; Knook DL; Kluft C; Slagboom PE
    Atherosclerosis; 2000 Mar; 149(1):91-7. PubMed ID: 10704619
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between M/L55-polymorphism of paraoxonase enzyme and oxidative DNA damage in patients with type 2 diabetes mellitus and in control subjects.
    Malin R; Rantalaiho V; Huang XH; Wirta O; Pasternack A; Leinonen JS; Alho H; Jokela H; Koivula T; Tanaka T; Okada K; Ochi H; Toyokuni S; Lehtimäki T
    Hum Genet; 1999; 105(1-2):179-80. PubMed ID: 10480377
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes.
    Adkins S; Gan KN; Mody M; La Du BN
    Am J Hum Genet; 1993 Mar; 52(3):598-608. PubMed ID: 7916578
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic variation in paraoxonase-1 and paraoxonase-2 is associated with variation in plasma lipoproteins in Alberta Hutterites.
    Boright AP; Connelly PW; Brunt JH; Scherer SW; Tsui LC; Hegele RA
    Atherosclerosis; 1998 Jul; 139(1):131-6. PubMed ID: 9699900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins.
    Mackness MI; Mackness B; Durrington PN; Connelly PW; Hegele RA
    Curr Opin Lipidol; 1996 Apr; 7(2):69-76. PubMed ID: 8743898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic variation in paraoxonase-2 is associated with variation in plasma lipoproteins in Canadian Oji-Cree.
    Hegele RA; Harris SB; Connelly PW; Hanley AJ; Tsui LC; Zinman B; Scherer SW
    Clin Genet; 1998 Nov; 54(5):394-9. PubMed ID: 9842991
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating microRNA Biomarkers of Diabetic Retinopathy.
    Joglekar MV; Januszewski AS; Jenkins AJ; Hardikar AA
    Diabetes; 2016 Jan; 65(1):22-4. PubMed ID: 26696637
    [No Abstract]   [Full Text] [Related]  

  • 54. Paraoxonase: another factor in NIDDM cardiovascular disease.
    Mackness MI; Durrington PN
    Lancet; 1995 Sep; 346(8979):856. PubMed ID: 7564664
    [No Abstract]   [Full Text] [Related]  

  • 55. Of genes and proliferative retinopathy.
    Barbosa J; Ramsay R
    Diabetologia; 1981 Apr; 20(4):506. PubMed ID: 7239046
    [No Abstract]   [Full Text] [Related]  

  • 56. [STUDY OF ALPH-BENZOYL-L-ARGININE-ETHYL-ESTER HEXOPEPTIDASE IN THE SERUM IN DIABETES MELLITUS].
    MESCHINO S; MEONI S
    Minerva Med; 1964 Feb; 55():291-4. PubMed ID: 14140223
    [No Abstract]   [Full Text] [Related]  

  • 57. Genetic contribution to retinopathy.
    Barbosa J; Ramsay R
    Diabetologia; 1980 Jun; 18(6):515. PubMed ID: 7418961
    [No Abstract]   [Full Text] [Related]  

  • 58. [THE NATURE AND PATHOGENESIS OF DIABETIC RETINOPATHY].
    ROSEN DA
    Union Med Can; 1963 Nov; 92():1288-91. PubMed ID: 14097151
    [No Abstract]   [Full Text] [Related]  

  • 59. Diabetic Retinopathy: Updates and Future Development.
    Ahmad M; Shaikh F
    Insight; 2016 Autumn; 41(4):18-26. PubMed ID: 30074708
    [No Abstract]   [Full Text] [Related]  

  • 60. Diabetic retinopathy.
    Nat Rev Dis Primers; 2016 Mar; 2():16013. PubMed ID: 27228470
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.